CAPSTONE ASSET MANAGEMENT CO - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 138 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPSTONE ASSET MANAGEMENT CO ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$303,000
+9.0%
27,590
-2.6%
0.01%0.0%
Q1 2017$278,000
-14.5%
28,340
-5.8%
0.01%
-11.1%
Q4 2016$325,000
+112.4%
30,090
+101.1%
0.01%
+125.0%
Q3 2016$153,000
-22.3%
14,960
-0.7%
0.00%
-33.3%
Q2 2016$197,00015,0700.01%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Sensato Investors LLC 1,552,482$13,755,0002.96%
Nantahala Capital Management 1,522,625$13,490,0002.24%
GLOBEFLEX CAPITAL L P 150,138$1,330,0000.25%
Ativo Capital Management LLC 71,563$634,0000.25%
MCKINLEY CAPITAL MANAGEMENT LLC 543,110$4,812,0000.19%
RFG Advisory, LLC 24,700$208,0000.16%
GSA CAPITAL PARTNERS LLP 345,833$3,064,0000.12%
Spark Investment Management LLC 95,900$849,0000.12%
Numeric Investors LLC 1,002,814$8,885,0000.11%
ClariVest Asset Management LLC 384,222$3,404,0000.10%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders